Answers are grounded in this paper and cite their sources.
Ultrasound imaging combined with ultrasound contrast agents (UCAs) has broad diagnostic applications. However, commercially available UCAs are typically micrometer-sized (1–8 µm), which largely confines them to the vascular compartment and limits their access to tumor interstitium. This study aimed to optimize the hydrodynamic diameter and in vitro echogenicity of hollow biodegradable poly(D,L-lactide-co-glycolide) nanoparticles (H-BPNPs) prepared by the emulsification–diffusion method using a three-factor, three-level Box–Behnken design. The independent variables were camphor amount (mg), stabilizer concentration (% w/v), and homogenization speed (rpm). The optimized H-BPNPs had a hydrodynamic diameter of 306.50 ± 2.09 nm, a polydispersity index of 0.05 ± 0.01, and a zeta potential of − 23.74 ± 0.23 mV. In vitro echogenicity studies showed that the optimized H-BPNPs produced greater mean grayscale value (MGV) enhancement than non-hollow PLGA nanoparticles (23.86 ± 0.63% vs 14.92 ± 0.58%). Scanning electron microscopy showed spherical particles, whereas differential scanning calorimetry indicated the absence of the camphor-associated thermal event after freeze-drying. Together with the increased echogenicity, these findings are consistent with the formation of low-density internal structures. The optimized H-BPNPs are promising candidates for further investigation as nanoscale UCAs; however, direct structural confirmation and in vivo validation are still required
No takes yet. Share an insight, caveat, or question.
Serrano-Mora et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: